Introducing InfoBits from Microbix
Microbix has a multifaceted business with a range of opportunities, including LumiSortTM (livestock semen sexing) and Kinlytic® (thrombolytic drug) and business opportunities being developed within the Virology business platform. Virology has grown from about $5 million in 2012 to almost $9 million in 2015, and there is a lot more potential that we’d like to share with you.
Today, we are introducing a new portal for communicating information about the many opportunities incubating at the Company. InfoBits will provide insight into the markets we are servicing, why customers rely on us as a supplier and interesting facts about the large and changing world of diagnostics where opportunities lurk.
We will be posting fresh content to InfoBits under the investor’s tab on our website each month. These posts will be updated regularly, so visit us as our story continues.